What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?

What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?

Sergio Rosales-Mendoza, Verónica A. Márquez-Escobar, Omar González-Ortega, Ricardo Nieto-Gómez, Jaime I. Arévalo-Villalobos

The emergence of new pathogenic viral strains is a constant threat to global health, with the new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS-CoV-2 virus has quickly spread around the globe. This pandemic demands rapid development of drugs and vaccines. Plant-based vaccines are a technology with proven viability, which have led to promising results for candidates evaluated at the clinical level, meaning this technology could contribute towards the fight against COVID-19. Herein, a perspective in how plant-based vaccines can be developed against COVID-19 is presented. Injectable vaccines could be generated by using transient expression systems, which offer the highest protein yields and are already adopted at the industrial level to produce VLPs-vaccines and other biopharmaceuticals under GMPC-processes. Stably-transformed plants are another option, but this approach requires more time for the development of antigen-producing lines. Nonetheless, this approach offers the possibility of developing oral vaccines in which the plant cell could act as the antigen delivery agent. Therefore, this is the most attractive approach in terms of cost, easy delivery, and mucosal immunity induction. The development of multiepitope, rationally-designed vaccines is also discussed regarding the experience gained in expression of chimeric immunogenic proteins in plant systems.

2020

zoonosis, multi-epitope vaccine, Molecular Farming, oral vaccines, epitope-based vaccine, mucosal immunization

DOI: 10.3390/vaccines8020183

Vaccines

MDPI AG

Medicine

EN